Showing 1 - 11 results of 11 for search 'Zong‐Han Liu', query time: 0.05s Refine Results
  1. 1
    Combination of alpha-fetoprotein and neutrophil-to-lymphocyte ratio to predict treatment response and survival outcomes of patients with unresectable hepatocellular carcinoma treated with immune checkpoint inhibitors

    Combination of alpha-fetoprotein and neutrophil-to-lymphocyte ratio to predict treatment response and survival outcomes of patients with unresectable hepatocellular carcinoma treat... by Hong-Fei Zhu, Jin-Kai Feng, Yan-Jun Xiang, Kang Wang, Li-Ping Zhou, Zong-Han Liu, Yu-Qiang Cheng, Jie Shi, Wei-Xing Guo, Shu-Qun Cheng

    Published 2023-06-01
    Get full text
    Article
  2. 2
    Overall survival of patients with hepatocellular carcinoma treated with sintilimab and disease outcome after treatment discontinuation

    Overall survival of patients with hepatocellular carcinoma treated with sintilimab and disease outcome after treatment discontinuation by Kang Wang, Yan-Jun Xiang, Hong-Ming Yu, Yu-Qiang Cheng, Jin-Kai Feng, Zong-Han Liu, Yun-Feng Shan, Yi-Tao Zheng, Qian-Zhi Ni, Shu-Qun Cheng

    Published 2023-10-01
    Get full text
    Article
  3. 3
    A reasonable identification of the early recurrence time based on microvascular invasion for hepatocellular carcinoma after R0 resection: A multicenter retrospective study

    A reasonable identification of the early recurrence time based on microvascular invasion for hepatocellular carcinoma after R0 resection: A multicenter retrospective study by Zong‐Han Liu, Zong‐Tao Chai, Jin‐Kai Feng, Yu‐Chao Hou, Xiu‐Ping Zhang, Zhen‐Hua Chen, Yan‐Jun Xiang, Wei‐Xing Guo, Jie Shi, Shu‐Qun Cheng

    Published 2023-05-01
    Get full text
    Article
  4. 4
    Network pharmacology-based analysis of Resinacein S against non-alcoholic fatty liver disease by modulating lipid metabolism

    Network pharmacology-based analysis of Resinacein S against non-alcoholic fatty liver disease by modulating lipid metabolism by Fei-Fei Mao, Shan-Shan Gao, Yan-Jie Huang, Nian Zhou, Jin-Kai Feng, Zong-Han Liu, Yu-Qing Zhang, Lu-Yun Yuan, Gang Wei, Shu-Qun Cheng, Shu-Qun Cheng

    Published 2023-02-01
    Get full text
    Article
  5. 5
    Prognostic Comparison Between Liver Resection and Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Patients With Bile Duct Tumor Thrombus: A Propensity-Score Matching Analysis

    Prognostic Comparison Between Liver Resection and Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Patients With Bile Duct Tumor Thrombus: A Propensity-Score M... by Zong-Han Liu, Ju-Xian Sun, Jin-Kai Feng, Shi-Ye Yang, Zhen-Hua Chen, Chang Liu, Zong-Tao Chai, Fei-Fei Mao, Wei-Xing Guo, Jie Shi, Shu-Qun Cheng

    Published 2022-03-01
    Get full text
    Article
  6. 6
    Preoperative and Prognostic Prediction of Microvascular Invasion in Hepatocellular Carcinoma: A Review Based on Artificial Intelligence

    Preoperative and Prognostic Prediction of Microvascular Invasion in Hepatocellular Carcinoma: A Review Based on Artificial Intelligence by Yu Jiang Master of Engineering, Kang Wang Master of Medicine, Yu-Ran Wang Master of Engineering, Yan-Jun Xiang Master of Medicine, Zong-Han Liu Doctor of Medicine, Jin-Kai Feng Doctor of Medicine, Shu-Qun Cheng Doctor of Medicine

    Published 2023-11-01
    Get full text
    Article
  7. 7
    Impact of type 2 diabetes mellitus on the prognosis of patients with hepatocellular carcinoma after laparoscopic liver resection: A multicenter retrospective study

    Impact of type 2 diabetes mellitus on the prognosis of patients with hepatocellular carcinoma after laparoscopic liver resection: A multicenter retrospective study by Shi-Ye Yang, Mao-Lin Yan, Jin-Kai Feng, Yun-Fei Duan, Jia-Zhou Ye, Zong-Han Liu, Lei Guo, Jie Xue, Jie Shi, Wan Yee Lau, Shu-Qun Cheng, Wei-Xing Guo

    Published 2022-12-01
    Get full text
    Article
  8. 8
    Efficacy and safety of TACE combined with lenvatinib and PD‐1 inhibitors for unresectable recurrent HCC: A multicenter, retrospective study

    Efficacy and safety of TACE combined with lenvatinib and PD‐1 inhibitors for unresectable recurrent HCC: A multicenter, retrospective study by Wei‐Jun Wang, Zong‐Han Liu, Kang Wang, Hong‐Ming Yu, Yu‐Qiang Cheng, Yan‐Jun Xiang, Jin‐Kai Feng, Li‐Ping Zhou, Hong‐Kun Zhou, Wei‐Wei Pan, Wei‐Xing Guo, Jie Shi, Shu‐Qun Cheng

    Published 2023-05-01
    Get full text
    Article
  9. 9
    Efficacy and safety of a triple combination of atezolizumab, bevacizumab plus GEMOX for advanced biliary tract cancer: a multicenter, single-arm, retrospective study

    Efficacy and safety of a triple combination of atezolizumab, bevacizumab plus GEMOX for advanced biliary tract cancer: a multicenter, single-arm, retrospective study by Kang Wang, Zong-Han Liu, Hong-Ming Yu, Yu-Qiang Cheng, Yan-Jun Xiang, Jing-Ya Zhong, Qian-Zhi Ni, Li-Ping Zhou, Chao Liang, Hong-Kun Zhou, Wei-Wei Pan, Wei-Xing Guo, Jie Shi, Shu-Qun Cheng

    Published 2023-03-01
    Get full text
    Article
  10. 10
    Efficacy and safety of transarterial chemoembolization plus antiangiogenic- targeted therapy and immune checkpoint inhibitors for unresectable hepatocellular carcinoma with portal vein tumor thrombus in the real world

    Efficacy and safety of transarterial chemoembolization plus antiangiogenic- targeted therapy and immune checkpoint inhibitors for unresectable hepatocellular carcinoma with portal... by Jin-Kai Feng, Zong-Han Liu, Zhi-Gang Fu, Zong-Tao Chai, Ju-Xian Sun, Kang Wang, Yu-Qiang Cheng, Hong-Fei Zhu, Yan-Jun Xiang, Yan-Jun Xiang, Li-Ping Zhou, Jie Shi, Wei-Xing Guo, Jian Zhai, Shu-Qun Cheng

    Published 2022-11-01
    Get full text
    Article
  11. 11
    Intensity-modulated radiotherapy combined with systemic atezolizumab and bevacizumab in treatment of hepatocellular carcinoma with extrahepatic portal vein tumor thrombus: A preliminary multicenter single-arm prospective study

    Intensity-modulated radiotherapy combined with systemic atezolizumab and bevacizumab in treatment of hepatocellular carcinoma with extrahepatic portal vein tumor thrombus: A prelim... by Kang Wang, Yan-Jun Xiang, Hong-Ming Yu, Yu-Qiang Cheng, Zong-Han Liu, Jing-Ya Zhong, Shuang Feng, Qian-Zhi Ni, Qian-Zhi Ni, Hong-Fei Zhu, Wei-Wei Pan, Wei-Wei Pan, Jing-Jing Li, Chao Liang, Hong-Kun Zhou, Yan Meng, Wan Yee Lau, Wan Yee Lau, Shu-Qun Cheng, Shu-Qun Cheng, Shu-Qun Cheng, Shu-Qun Cheng

    Published 2023-02-01
    Get full text
    Article

Search Tools: